ATP release mechanisms

Nucleotides and Regulation of Bone Cell Function

Volumn , Issue , 2006, Pages 99-158

  Dubyak, George R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887996220     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (374)

1. Burnstock, G., Purinergic nerves, Pharmacol. Rev., 24, 509, 1972.
2. White, T.D., Direct detection of depolarisation-induced release of ATP from a synaptosomal preparation, Nature, 267, 67, 1977.
3. Burnstock, G., et al., Direct evidence for ATP release from non-adrenergic, non-cholinergic (“purinergic”) nerves in the guinea-pig taenia coli and bladder, Eur. J. Pharmacol., 49, 145, 1978.
4. Holmsen, H., Biochemistry of the platelet release reaction, Ciba Found. Symp., 35, 175, 1975.
5. Macfarlane, D.E., et al., The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation, Br. J. Haematol., 30, 457, 1975.
6. Holmsen, H., et al., Short communication: possible association of newly absorbed serotonin with nonmetabolic, granule-located adenine nucleotides in human blood platelets, Blood, 45, 413, 1975.
7. Ralevic, V. and Burnstock, G., Receptors for purines and pyrimidines, Pharmacol. Rev., 50, 413, 1998.
8. Shaver, S.R., P2Y receptors: biological advances and therapeutic opportunities, Curr. Opin. Drug Discov. Devel., 4, 665, 2001.
9. Lazarowski, E.R., et al., Mechanisms of release of nucleotides and integration of their action as P2X-and P2Y-receptor activating molecules, Mol. Pharmacol., 64, 785, 2003.
10. North, R.A., Molecular physiology of P2X receptors, Physiol. Rev., 82, 1013, 2002.
11. Girdler, G. and Khakh, B.S., ATP-gated P2X channels, Curr. Biol., 14, R6, 2004.
12. Fredholm, B.B., et al., International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors, Pharmacol. Rev., 53, 527, 2001.
13. Linden, J., Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection, Ann. Rev. Pharmacol. Toxicol., 41, 775, 2001.
14. Zimmermann, H., 5'-Nucleotidase: molecular structure and functional aspects, Biochem. J., 285, 345, 1992.
15. Zimmermann, H., Extracellular metabolism of ATP and other nucleotides, N. Schmied. Arch. Pharmacol., 362, 299, 2000.
16. Zimmermann, H., Two novel families of ectonucleotidases: molecular structures, catalytic properties and a search for function, Trends Pharmacol. Sci., 20, 231, 1999.
17. Robson, S.C., et al., Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation, Semin. Thromb. Hemost., 31, 217, 2005.
18. Stefan, C., et al., NPP-type ectophosphodiesterases: unity in diversity, Trends Biochem. Sci., 30, 542, 2005.
19. Milner, P., et al., Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow, Proc. Biol. Sci., 241, 245, 1990.
20. Milner, P., et al., Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow, Biochem. Biophys. Res. Commun., 170, 649, 1990.
21. Osipchuk, Y. and Cahalan, M., Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells, Nature, 359, 241, 1992.
22. Wang, Y., et al., Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation, Proc. Natl. Acad. Sci. USA, 93, 12020, 1996.
23. Roman, R.M., et al., Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume, J. Biol. Chem., 272, 21970, 1997.
24. Watt, W.C., et al., Cystic fibrosis transmembrane regulator-independent release of ATP. Its implications for the regulation of P2Y2 receptors in airway epithelia, J. Biol. Chem., 273, 14053, 1998.
25. Schwiebert, E.M., ABC transporter-facilitated ATP conductive transport, Am. J. Physiol., 276, C1, 1999.
26. Feranchak, A.P., et al., Volume-sensitive purinergic signaling in human hepatocytes, J. Hepatol., 33, 174, 2000.
27. Ostrom, R.S., et al., Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways, J. Biol. Chem., 275, 11735, 2000.
28. Schwiebert, E.M. and Zsembery, A., Extracellular ATP as a signaling molecule for epithelial cells, Biochim. Biophys. Acta, 1615, 7, 2003.
29. Sauer, H., et al., Mechanical strain-induced Ca2+ waves are propagated via ATP release and purinergic receptor activation, Am. J. Physiol., 279, C295, 2000.
30. Roman, R.M., et al., Evidence for multidrug resistance-1 P-glycoprotein-dependent regulation of cellular ATP permeability, J. Membr. Biol., 183, 165, 2001.
31. Hisadome, K., et al., Volume-regulated anion channels serve as an auto/paracrine nucleotide release pathway in aortic endothelial cells, J. Gen. Physiol., 119, 511, 2002.
32. Bennett, M.V., et al., New roles for astrocytes: gap junction hemichannels have something to communicate, Trends Neurosci., 26, 610, 2003.
33. Sabirov, R.Z. and Okada, Y., ATP-conducting maxi-anion channel: a new player in stress-sensory transduction, Jpn. J. Physiol., 54, 7, 2004.
34. Crane, J.K., et al., Two pathways for ATP release from host cells in enteropathogenic Escherichia coli infection, Am. J. Physiol., 289, G407, 2005.
35. Buxton, I.L., et al., Evidence supporting the Nucleotide Axis Hypothesis: ATP release and metabolism by coronary endothelium, Am. J. Physiol., 281, H1657, 2001.
36. Yegutkin, G.G., et al., Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions, FASEB J., 15, 251, 2001.
37. Yegutkin, G.G., et al., The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells, Biochem. J., 367, 121, 2002.
38. Joseph, S.M., et al., Methylene ATP analogs as modulators of extracellular ATP metabolism and accumulation, Br. J. Pharmacol., 142, 1002, 2004.
39. Burrell, H.E., et al., Human keratinocytes release ATP and utilize three mechanisms for nucleotide interconversion at the cell surface, J. Biol. Chem., 280, 29667, 2005.
40. Lazarowski, E.R., et al., Identification of an ecto-nucleoside diphosphokinase and its contribution to interconversion of P2 receptor agonists, J. Biol. Chem., 272, 20402, 1997.
41. Lazarowski, E.R. and Harden, T.K., Quantitation of extracellular UTP using a sensitive enzymatic assay, Br. J. Pharmacol., 127, 1272, 1999.
42. Donaldson, S.H., et al., Basal nucleotide levels, release, and metabolism in normal and cystic fibrosis airways, Mol. Med., 6, 969, 2000.
43. Lazarowski, E.R., et al., Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations, J. Biol. Chem., 275, 31061, 2000.
44. Muller, C.E., P2-pyrimidinergic receptors and their ligands, Curr. Pharm. Des., 8, 2353, 2002.
45. Lazarowski, E.R., et al., Release of cellular UDP-glucose as a potential extracellular signaling molecule, Mol. Pharmacol., 63, 1190, 2003.
46. Hazama, A., et al., Cell surface measurements of ATP release from single pancreatic beta cells using a novel biosensor technique, Pflugers Arch., 437, 31, 1998.
47. Roman, R.M., et al., Endogenous ATP release regulates Cl-secretion in cultured human and rat biliary epithelial cells, Am. J. Physiol., 276, G1391, 1999.
48. Van der Wijk, T., et al., Osmotic cell swelling-induced ATP release mediates the activation of extracellular signal-regulated protein kinase (Erk)-1/2 but not the activation of osmo-sensitive anion channels, Biochem. J., 343, 579, 1999.
49. Hazama, A., et al., Swelling-activated, cystic fibrosis transmembrane conductance regulator-augmented ATP release and Cl-conductances in murine C127 cells, J. Physiol., 523, 1, 2000.
50. Braet, K., et al., Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26, Cell Calcium, 33, 37, 2003.
51. Darby, M., et al., ATP released from astrocytes during swelling activates chloride channels, J. Neurophysiol., 89, 1870, 2003.
52. van der Wijk, T., et al., Increased vesicle recycling in response to osmotic cell swelling. Cause and consequence of hypotonicity-provoked ATP release, J. Biol. Chem., 278, 40020, 2003.
53. Buttigieg, J. and Nurse, C.A., Detection of hypoxia-evoked ATP release from chemoreceptor cells of the rat carotid body, Biochem. Biophys. Res. Commun., 322, 82, 2004.
54. Kawakami, M., et al., Hypo-osmotic potentiation of acetylcholine-stimulated ciliary beat frequency through ATP release in rat tracheal ciliary cells, Exp. Physiol., 89, 739, 2004.
55. Okada, S.F., et al., Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell volume regulation in murine cells, J. Gen. Physiol., 124, 513, 2004.
56. Selzner, N., et al., Water induces autocrine stimulation of tumor cell killing through ATP release and P2 receptor binding, Cell Death Differ., 11, S172, 2004.
57. Solini, A., et al., Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes, Arterioscler. Thromb. Vasc. Biol., 24, 1240, 2004.
58. Bianco, F., et al., Astrocyte-derived ATP induces vesicle shedding and IL-1ß release from microglia, J. Immunol., 174, 7268, 2005.
59. Genetos, D.C., et al., Fluid shear-induced ATP secretion mediates prostaglandin release in MC3T3-E1 osteoblasts, J. Bone Miner. Res., 20, 41, 2005.
60. Patel, A.S., et al., Paracrine stimulation of surfactant secretion by extracellular ATP in response to mechanical deformation, Am. J. Physiol., 289, L489, 2005.
61. Wang, L., et al., ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells, Circ. Res., 96, 189, 2005.
62. Picher, M., et al., Ecto 5'-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways, J. Biol. Chem., 278, 13468, 2003.
63. Kansas, G.S., et al., Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes, J. Immunol., 146, 2235, 1991.
64. Kaczmarek, E., et al., Identification and characterization of CD39/vascular ATP diphosphohydrolase, J. Biol. Chem., 271, 33116, 1996.
65. Wang, T.F. and Guidotti, G., CD39 is an ecto-(Ca2+, Mg2+)-apyrase, J. Biol. Chem., 271, 9898, 1996.
66. Chadwick, B.P. and Frischauf, A.M., Cloning and mapping of a human and mouse gene with homology to ecto-ATPase genes, Mamm. Genome, 8, 668, 1997.
67. Marcus, A.J., et al., The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39, J. Clin. Invest., 99, 1351, 1997.
68. Enjyoji, K., et al., Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation, Nat. Med., 5, 1010, 1999.
69. Koziak, K., et al., Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes, Thromb. Haemost., 82, 1538, 1999.
70. Wang, T.F., et al., The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structure, J. Biol. Chem., 273, 24814, 1998.
71. Chadwick, B.P. and Frischauf, A.M., The CD39-like gene family: identification of three new human members (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of the gene family from Drosophila melanogaster, Genomics, 50, 357, 1998.
72. Smith, T.M. and Kirley, T.L., Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases1, Biochim. Biophys. Acta, 1386, 65, 1998.
73. Mateo, J., et al., Functional expression of a cDNA encoding a human ecto-ATPase, Br. J. Pharmacol., 128, 396, 1999.
74. Hicks-Berger, C.A. and Kirley, T.L., Expression and characterization of human ecto-ATPase and chimeras with CD39 ecto-apyrase, IUBMB Life, 50, 43, 2000.
75. Yang, F., et al., Site-directed mutagenesis of human nucleoside triphosphate diphosphohydrolase 3: the importance of residues in the apyrase conserved regions, Biochemistry, 40, 3943, 2001.
76. Wang, T.F. and Guidotti, G., Golgi localization and functional expression of human uridine diphosphatase, J. Biol. Chem., 273, 11392, 1998.
77. Yeung, G., et al., CD39L2, a gene encoding a human nucleoside diphosphatase, predominantly expressed in the heart, Biochemistry, 39, 12916, 2000.
78. Murphy-Piedmonte, D.M., et al., Bacterial expression, folding, purification and characterization of soluble NTPDase5 (CD39L4) ecto-nucleotidase, Biochim. Biophys. Acta, 1747, 251, 2005.
79. Ivanenkov, V.V., et al., Bacterial expression, characterization, and disulfide bond determination of soluble human NTPDase6 (CD39L2) nucleotidase: implications for structure and function, Biochemistry, 42, 11726, 2003.
80. Hicks-Berger, C.A., et al., Expression and characterization of soluble and membrane-bound human nucleoside triphosphate diphosphohydrolase 6 (CD39L2), J. Biol. Chem., 275, 34041, 2000.
81. Mulero, J.J., et al., CD39-L4 is a secreted human apyrase, specific for the hydrolysis of nucleoside diphosphates, J. Biol. Chem., 274, 20064, 1999.
82. Braun, N., et al., Sequencing, functional expression and characterization of rat NTPDase6, a nucleoside diphosphatase and novel member of the ecto-nucleoside triphosphate diphosphohydrolase family, Biochem. J., 351, 639, 2000.
83. Sevigny, J., et al., Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation, Blood, 99, 2801, 2002.
84. Failer, B.U., et al., Determination of native oligomeric state and substrate specificity of rat NTPDase1 and NTPDase2 after heterologous expression in Xenopus oocytes, Eur. J. Biochem., 270, 1802, 2003.
85. Stefan, C., et al., Differential regulation of the expression of nucleotide pyrophosphatases/phosphodiesterases in rat liver, Biochim. Biophys. Acta, 1450, 45, 1999.
86. Hessle, L., et al., Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization, Proc. Natl. Acad. Sci. USA, 99, 9445, 2002.
87. Rutsch, F., et al., PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification, Am. J. Pathol., 158, 543, 2001.
88. Johnson, K., et al., Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression, J. Bone Miner. Res., 18, 994, 2003.
89. Rutsch, F., et al., Mutations in ENPP1 are associated with “idiopathic” infantile arterial calcification, Nat. Genet., 34, 379, 2003.
90. Johnson, K., et al., Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/-mice, Arterioscler. Thromb. Vasc. Biol., 25, 686, 2005.
91. Maddux, B.A., et al., Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus, Nature, 373, 448, 1995.
92. Goldfine, I.D., et al., Role of PC-1 in the etiology of insulin resistance, Ann. NY Acad. Sci., 892, 204, 1999.
93. Meyre, D., et al., Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes, Nat. Genet., 37, 863, 2005.
94. Maddux, B.A., et al., Overexpression of the insulin receptor inhibitor, PC-1/NPP1, induces insulin resistance and hyperglycemia, Am. J. Physiol. [Epub ahead of print, 8/11/05] 2005.
95. Gijsbers, R., et al., The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site, FEBS Lett., 538, 60, 2003.
96. Cimpean, A., et al., Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2, Biochem. J., 381, 71, 2004.
97. Bollen, M., et al., Nucleotide pyrophosphatases/phosphodiesterases on the move, Crit. Rev. Biochem. Mol. Biol., 35, 393, 2000.
98. Meerson, N.R., et al., Intracellular traffic of the ecto-nucleotide pyrophosphatase/phosphodiesterase NPP3 to the apical plasma membrane of MDCK and Caco-2 cells: apical targeting occurs in the absence of N-glycosylation, J. Cell Sci., 113, 4193, 2000.
99. Yano, Y., et al., Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-3 (E-NPP3/CD203c/PD-I beta/B10/gp130RB13-6) in human colon carcinoma, Int. J. Mol. Med., 12, 763, 2003.
100. Buhring, H.J., et al., The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis, Int. Arch. Allergy Immunol., 133, 317, 2004.
101. Vaingankar, S.M., et al., Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1, Am. J. Physiol., 286, C1177, 2004.
102. Yano, Y., et al., Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-1 (E-NPP1/PC-1) and -3 (E-NPP3/CD203c/PD-Ibeta/B10/gp130(RB13-6)) in inflammatory and neoplastic bile duct diseases, Cancer Lett., 207, 139, 2004.
103. Jansen, S., et al., Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D, J. Cell Sci., 118, 3081, 2005.
104. Resta, R., et al., Ecto-enzyme and signaling functions of lymphocyte CD73, Immunol. Rev., 161, 95, 1998.
105. Resta, R., et al., Murine ecto-5'-nucleotidase (CD73): cDNA cloning and tissue distribution, Gene, 133, 171, 1993.
106. Resta, R., et al., Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73, J. Immunol., 153, 1046, 1994.
107. Boudreault, F. and Grygorczyk, R., Cell swelling-induced ATP release is tightly dependent on intracellular calcium elevations, J. Physiol., 561, 499, 2004.
108. Guyot, A. and Hanrahan, J.W., ATP release from human airway epithelial cells studied using a capillary cell culture system, J. Physiol., 545, 199, 2002.
109. Plock, N. and Kloft, C., Microdialysis-theoretical background and recent implementation in applied life-sciences, Eur. J. Pharm. Sci., 25, 1, 2005.
110. Matsuka, Y., et al., Concurrent release of ATP and substance P within guinea pig trigeminal ganglia in vivo, Brain Res., 915, 248, 2001.
111. Melani, A., et al., ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia, Neurochem. Int., 47, 442, 2005.
112. Neubert, J.K., et al., Microdialysis in trigeminal ganglia, Brain Res. Brain Res. Protoc., 10, 102, 2002.
113. Nishiyama, A., et al., Relation between renal interstitial ATP concentrations and autoregulation-mediated changes in renal vascular resistance, Circ. Res., 86, 656, 2000.
114. Headrick, J.P., et al., Interstitial adenosine and cellular metabolism during beta-adrenergic stimulation of the in situ rabbit heart, Cardiovasc. Res., 31, 699, 1996.
115. Harrison, G.J., et al., Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart, Cardiovasc. Res., 40, 74, 1998.
116. Kuzmin, A.I., et al., Interstitial ATP level and degradation in control and postmyocardial infarcted rats, Am. J. Physiol., 275, C766, 1998.
117. Kuzmin, A.I., et al., Effects of preconditioning on myocardial interstitial levels of ATP and its catabolites during regional ischemia and reperfusion in the rat, Basic Res. Cardiol., 95, 127, 2000.
118. Sato, T., et al., Nicorandil increases adenosine 5'-monophosphate-primed interstitial adenosine via activation of ecto-5'-nucleotidase in rat hearts, Heart Vessels, 15, 81, 2000.
119. Ninomiya, H., et al., Complementary role of extracellular ATP and adenosine in ischemic preconditioning in the rat heart, Am. J. Physiol., 282, H1810, 2002.
120. Obata, T., Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium, Life Sci., 71, 2083, 2002.
121. Gourine, A.V., et al., Interstitial purine metabolites in hearts with LV remodeling, Am. J. Physiol., 286, H677, 2004.
122. Zakaria, M. and Brown, P.R., High-performance liquid chromatography of nucleotides, nucleosides and bases, J. Chromatogr., 226, 267, 1981.
123. Stevens, P., et al., Synthesis, storage and drug-induced release of atp-8-3h in the perfused bovine adrenal gland, Pharmacology, 13, 40, 1975.
124. Pearson, J.D. and Gordon, J.L., Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides, Nature, 281, 384, 1979.
125. Westfall, D.P., et al., Release of endogenous ATP from rat caudal artery, Blood Vessels, 24, 125, 1987.
126. Yang, S., et al., Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells, Circ. Res., 74, 401, 1994.
127. McConalogue, K., et al., Direct measurement of the release of ATP and its major metabolites from the nerve fibres of the guinea-pig taenia coli, Clin. Exp. Pharmacol. Physiol., 23, 807, 1996.
128. Shinozuka, K., et al., In vitro studies of release of adenine nucleotides and adenosine from rat vascular endothelium in response to alpha 1-adrenoceptor stimulation, Br. J. Pharmacol., 113, 1203, 1994.
129. Shinozuka, K., et al., Differences in purinoceptor modulation of norepinephrine release between caudal arteries of normotensive and hypertensive rats, J. Pharmacol. Exp. Ther., 272, 1193, 1995.
130. Hashimoto, M., et al., Source of ATP, ADP, AMP and adenosine released from isolated rat caudal artery exposed to noradrenaline, J. Smooth Muscle Res., 33, 127, 1997.
131. Shinozuka, K., et al., Regional differences in noradrenaline-induced release of adenosine triphosphate from rat vascular endothelium, J. Smooth Muscle Res., 33, 135, 1997.
132. Kawamoto, Y., et al., Determination of ATP and its metabolites released from rat caudal artery by isocratic ion-pair reversed-phase high-performance liquid chromatography, Anal. Biochem., 262, 33, 1998.
133. Lazarowski, E.R., et al., Nucleotide release provides a mechanism for airway surface liquid homeostasis, J. Biol. Chem., 279, 36855, 2004.
134. Denburg, J.L. and McElroy, W.D., Catalytic subunit of firefly luciferase, Biochemistry, 9, 4619, 1970.
135. Lee, R.T., et al., Substrate-binding properties of firefly luciferase. II. ATP-binding site, Arch. Biochem. Biophys., 141, 38, 1970.
136. Denburg, J.L., et al., Substrate-binding properties of firefly luciferase. I. Luciferin-binding site, Arch. Biochem. Biophys., 134, 381, 1969.
137. Kimmich, G.A., et al., Assay of picomole amounts of ATP, ADP, and AMP using the luciferase enzyme system, Anal. Biochem., 69, 187, 1975.
138. McElroy, W.D. and DeLuca, M.A., Firefly and bacterial luminescence: basic science and applications, J. Appl. Biochem., 5, 197, 1983.
139. Leach, F.R. and Webster, J.J., Commercially available firefly luciferase reagents, Meth. Enzymol., 133, 51, 1986.
140. Ford, S.R., et al., Enhancement of firefly luciferase activity by cytidine nucleotides, Anal. Biochem., 204, 283, 1992.
141. Ford, S.R., et al., Bioluminescent determination of 0.1 picomole amounts of guanine nucleotides, J. Biolumin. Chemilumin., 9, 251, 1994.
142. Ford, S.R., et al., Effect of periodate-oxidized ATP and other nucleotides on firefly luciferase, Arch. Biochem. Biophys., 314, 261, 1994.
143. Ford, S.R., et al., Use of firefly luciferase for ATP measurement: other nucleotides enhance turnover, J. Biolumin. Chemilumin., 11, 149, 1996.
144. Holmsen, H., et al., Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma, Anal. Biochem., 46, 489, 1972.
145. Borst, M.M. and Schrader, J., Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine, Circ. Res., 68, 797, 1991.
146. Brovko, L., et al., Bioluminescent assay of bacterial intracellular AMP, ADP, and ATP with the use of a coimmobilized three-enzyme reagent (adenylate kinase, pyruvate kinase, and firefly luciferase), Anal. Biochem., 220, 410, 1994.
147. Gorman, M.W., et al., Measurement of adenine nucleotides in plasma, Luminescence, 18, 173, 2003.
148. Ishii, S., et al., A novel method for determination of ATP, ADP, and AMP contents of a single pancreatic islet before transplantation, Transplant Proc., 36, 1191, 2004.
149. White, T.D., Release of ATP from a synaptosomal preparation by elevated extracellular K+ and by veratridine, J. Neurochem., 30, 329, 1978.
150. White, T., et al., Tetrodotoxin-resistant release of ATP from guinea-pig taenia coli and vas deferens during electrical field stimulation in the presence of luciferin-luciferase, Can. J. Physiol. Pharmacol., 59, 1094, 1981.
151. White, T.D., et al., Direct and continuous detection of ATP secretion from primary monolayer cultures of bovine adrenal chromaffin cells, J. Neurochem., 49, 1266, 1987.
152. Rojas, E., et al., Real-time measurements of acetylcholine-induced release of ATP from bovine medullary chromaffin cells, FEBS Lett., 185, 323, 1985.
153. Cena, V. and Rojas, E., Kinetic characteristics of calcium-dependent, cholinergic receptor controlled ATP secretion from adrenal medullary chromaffin cells, Biochim. Biophys. Acta, 1023, 213, 1990.
154. Fiedler, J.L., et al., Quantitative analysis of depolarization-induced ATP release from mouse brain synaptosomes: external calcium dependent and independent processes, J. Membr. Biol., 127, 21, 1992.
155. Taylor, A.L., et al., Bioluminescence detection of ATP release mechanisms in epithelia, Am. J. Physiol., 275, C1391, 1998.
156. Schwiebert, L.M., et al., Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells, Am. J. Physiol., 282, C289, 2002.
157. Baggett, B., et al., Thermostability of firefly luciferases affects efficiency of detection by in vivo bioluminescence, Mol. Imaging, 3, 324, 2004.
158. Boudreault, F. and Grygorczyk, R., Cell swelling-induced ATP release and gadolinium-sensitive channels, Am. J. Physiol., 282, C219, 2002.
159. Maroto, R. and Hamill, O.P., Brefeldin A block of integrin-dependent mechanosensitive ATP release from Xenopus oocytes reveals a novel mechanism of mechanotransduction, J. Biol. Chem., 276, 23867, 2001.
160. Webster, J.J., et al., Buffer effects on ATP analysis by firefly luciferase, Anal. Biochem., 106, 7, 1980.
161. Beigi, R.D. and Dubyak, G.R., Endotoxin activation of macrophages does not induce ATP release and autocrine stimulation of P2 nucleotide receptors, J. Immunol., 165, 7189, 2000.
162. Beigi, R., et al., Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase, Am. J. Physiol., 276, C267, 1999.
163. Joseph, S.M., et al., Colocalization of ATP release sites and ecto-ATPase activity at the extracellular surface of human astrocytes, J. Biol. Chem., 278, 23331, 2003.
164. Godecke, S., et al., Do rat cardiac myocytes release ATP on contraction?, Am. J. Physiol., 289, C609, 2005.
165. Pellegatti, P., et al., A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion, Mol. Biol. Cell., 16, 3659, 2005.
166. Wang, Z., et al., Direct observation of calcium-independent intercellular ATP signaling in astrocytes, Anal. Chem., 72, 2001, 2000.
167. Arcuino, G., et al., Intercellular calcium signaling mediated by point-source burst release of ATP, Proc. Natl. Acad. Sci. USA, 99, 9840, 2002.
168. Gruenhagen, J.A., et al., Monitoring real-time release of ATP from the molluscan central nervous system, J. Neurosci. Meth., 139, 145, 2004.
169. Newman, E.A., Glial cell inhibition of neurons by release of ATP, J. Neurosci., 23, 1659, 2003.
170. Wang, X., et al., P2X7 receptor inhibition improves recovery after spinal cord injury, Nat. Med., 10, 821, 2004.
171. Sorensen, C.E. and Novak, I., Visualization of ATP release in pancreatic acini in response to cholinergic stimulus. Use of fluorescent probes and confocal microscopy, J. Biol. Chem., 276, 32925, 2001.
172. Bodin, P. and Burnstock, G., Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. J. Cardiovasc. Pharmacol., 38, 900, 2001.
173. Mitchell, C.H., et al., A release mechanism for stored ATP in ocular ciliary epithelial cells, Proc. Natl. Acad. Sci. USA, 95, 7174, 1998.
174. White, P.N., et al., Quinacrine staining of marginal cells in the stria vascularis of the guinea-pig cochlea: a possible source of extracellular ATP?, Hear. Res., 90, 97, 1995.
175. Bell, P.D., et al., Macula densa cell signaling involves ATP release through a maxi anion channel, Proc. Natl. Acad. Sci. USA, 100, 4322, 2003.
176. Hayashi, S., et al., Detecting ATP release by a biosensor method, Sci. STKE, 2004, pl14, 2004.
177. Dutta, A.K., et al., Role of ATP-conductive anion channel in ATP release from neonatal rat cardiomyocytes in ischaemic or hypoxic conditions, J. Physiol., 559, 799, 2004.
178. Hazama, A., et al., Swelling-induced, CFTR-independent ATP release from a human epithelial cell line: lack of correlation with volume-sensitive Cl-channels, J. Gen. Physiol., 114, 525, 1999.
179. Llaudet, E., et al., Microelectrode biosensor for real-time measurement of ATP in biological tissue, Anal. Chem., 77, 3267, 2005.
180. Gourine, A.V., et al., Release of ATP in the ventral medulla during hypoxia in rats: role in hypoxic ventilatory response, J. Neurosci., 25, 1211, 2005.
181. Schneider, S.W., et al., Continuous detection of extracellular ATP on living cells by using atomic force microscopy, Proc. Natl. Acad. Sci. USA, 96, 12180, 1999.
182. Ehrenhofer, U., et al., The atomic force microscope detects ATP-sensitive protein clusters in the plasma membrane of transformed MDCK cells, Cell Biol. Int., 21, 737, 1997.
183. Rakowska, A., et al., ATP-induced shape change of nuclear pores visualized with the atomic force microscope, J. Membr. Biol., 163, 129, 1998.
184. Imai, M., et al., Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells, Biochemistry, 38, 13473, 1999.
185. Grygorczyk, R. and Hanrahan, J.W., CFTR-independent ATP release from epithelial cells triggered by mechanical stimuli, Am. J. Physiol., 272, C1058, 1997.
186. Roman, R.M., et al., Evidence for Gd3+ inhibition of membrane ATP permeability and purinergic signaling, Am. J. Physiol., 277, G1222, 1999.
187. Salter, K.D., et al., Domain-specific purinergic signaling in polarized rat cholangiocytes, Am. J. Physiol., 278, G492, 2000.
188. Braunstein, G.M., et al., Cystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation, J. Biol. Chem., 276, 6621, 2001.
189. Gatof, D., et al., Vesicular exocytosis contributes to volume-sensitive ATP release in biliary cells, Am. J. Physiol., 286, G538, 2004.
190. Forrester, T. and Williams, C.A., Effect of pH and Ca2+ on ATP release from isolated adult heart cells, J. Physiol., 272, 44P, 1977.
191. Lazarowski, E.R., et al., Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation, J. Biol. Chem., 272, 24348, 1997.
192. Madara, J.L., et al., 5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers, J. Clin. Invest., 91, 2320, 1993.
193. Baricordi, O.R., et al., Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor, J. Biol. Chem., 274, 33206, 1999.
194. Rutsch, F. and Terkeltaub, R., Deficiencies of physiologic calcification inhibitors and low-grade inflammation in arterial calcification: lessons for cartilage calcification, Joint Bone Spine, 72, 110, 2005.
195. Abedin, M., et al., Vascular calcification: mechanisms and clinical ramifications, Arterioscler. Thromb. Vasc. Biol. 24, 1161, 2004.
196. Towler, D.A., Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype, Arterioscler. Thromb. Vasc. Biol., 25, 651, 2005.
197. Hirschberg, C.B., et al., Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus, Ann. Rev. Biochem., 67, 49, 1998.
198. Berninsone, P.M. and Hirschberg, C.B., Nucleotide sugar transporters of the Golgi apparatus, Curr. Opin. Struct. Biol., 10, 542, 2000.
199. Unsworth, C.D. and Johnson, R.G., Acetylcholine and ATP are coreleased from the electromotor nerve terminals of Narcine brasiliensis by an exocytotic mechanism, Proc. Natl. Acad. Sci. USA, 87, 553, 1990.
200. Morel, N. and Meunier, F.M., Simultaneous release of acetylcholine and ATP from stimulated cholinergic synaptosomes, J. Neurochem., 36, 1766, 1981.
201. Richardson, P.J. and Brown, S.J., ATP release from affinity-purified rat cholinergic nerve terminals, J. Neurochem., 48, 622, 1987.
202. Schweitzer, E., Coordinated release of ATP and ACh from cholinergic synaptosomes and its inhibition by calmodulin antagonists, J. Neurosci., 7, 2948, 1987.
203. Stjarne, L., et al., Spatiotemporal pattern of quantal release of ATP and noradrenaline from sympathetic nerves: consequences for neuromuscular transmission, Adv. Sec. Messenger Phosphoprotein Res., 29, 461, 1994.
204. Palaty, V., Swelling of the small adrenergic storage vesicles and the loss of vesicular ATP induced by cocaine in the isolated rat tail artery, N. Schmied. Arch. Pharmacol., 343, 149, 1991.
205. Baumgartner, H., et al., Isolated chromaffin granules maintenance of ATP content during incubation at 31 degrees C, Eur. J. Pharmacol., 22, 102, 1973.
206. Bankston, L.A. and Guidotti, G., Characterization of ATP transport into chromaffin granule ghosts, Synergy of ATP and serotonin accumulation in chromaffin granule ghosts, J. Biol. Chem., 271, 17132, 1996.
207. Weber, A., et al., Specificity and properties of the nucleotide carrier in chromaffin granules from bovine adrenal medulla, Biochem. J., 210, 789, 1983.
208. Bevington, A., et al., Phosphorus-31 nuclear magnetic resonance studies of pig adrenal glands, Neuroscience, 11, 281, 1984.
209. Costa, J.L., et al., Effects of osmotic dehydration on the nucleotides of isolated chromaffin granules: evaluation by 31p nuclear magnetic resonance, Res. Commun. Chem. Pathol. Pharmacol., 45, 389, 1984.
210. Holmsen, H. and Weiss, H.J., Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia-“storage pool disease,” Blood, 39, 197, 1972.
211. Daniel, J.L., et al., Radioactive labeling of the adenine nucleotide pool of cells as a method to distinguish among intracellular compartments. Studies on human platelets, Biochim. Biophys. Acta, 632, 444, 1980.
212. Meyers, K.M., et al., Comparative study of platelet dense granule constituents, Am. J. Physiol., 243, R454, 1982.
213. Ugurbil, K., et al., 31P NMR studies of nucleotide storage in the dense granules of pig platelets, Biochemistry, 23, 409, 1984.
214. Obermuller, S., et al., Selective nucleotide-release from dense-core granules in insulin-secreting cells, J. Cell. Sci., 118, 4271, 2005.
215. Jedlitschky, G., et al., The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage, Blood, 104, 3603, 2004.
216. Ritter, C.A., et al., Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5), Drug Metab. Rev., 37, 253, 2005.
217. Forrester, T. and Williams, C.A., Release of adenosine triphosphate from isolated adult heart cells in response to hypoxia, J. Physiol., 268, 371, 1977.
218. Williams, C.A. and Forrester, T., Possible source of adenosine triphosphate released from rat myocytes in response to hypoxia and acidosis, Cardiovasc. Res., 17, 301, 1983.
219. Sprague, R.S., et al., Deformation-induced ATP release from red blood cells requires CFTR activity, Am. J. Physiol., 275, H1726, 1998.
220. Graff, R.D., et al., ATP release by mechanically loaded porcine chondrons in pellet culture, Arthritis Rheum., 43, 1571, 2000.
221. John, K. and Barakat, A.I., Modulation of ATP/ADP concentration at the endothelial surface by shear stress: effect of flow-induced ATP release, Ann. Biomed. Eng., 29, 740, 2001.
222. Romanello, M., et al., Mechanically induced ATP release from human osteoblastic cells, Biochem. Biophys. Res. Commun., 289, 1275, 2001.
223. Srinivas, S.P., et al., Shear-induced ATP release by cultured rabbit corneal epithelial cells, Adv. Exp. Med. Biol., 506, 677, 2002.
224. Aleu, J., et al., Release of ATP induced by hypertonic solutions in Xenopus oocytes, J. Physiol., 547, 209, 2003.
225. Birder, L.A., et al., Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium, Am. J. Physiol., 285, F423, 2003.
226. Yamazaki, S., et al., Annulus cells release ATP in response to vibratory loading in vitro, J. Cell. Biochem., 90, 812, 2003.
227. Furuya, K., et al., Characteristics of subepithelial fibroblasts as a mechano-sensor in the intestine: cell-shape-dependent ATP release and P2Y1 signaling, J. Cell Sci., 118, 3289, 2005.
228. Gomes, P., et al., ATP release through connexin hemichannels in corneal endothelial cells, Invest. Ophthalmol. Vis. Sci., 46, 1208, 2005.
229. Romanello, M., et al., Autocrine/paracrine stimulation of purinergic receptors in osteoblasts: contribution of vesicular ATP release, Biochem. Biophys. Res. Commun., 331, 1429, 2005.
230. Bergfeld, G.R. and Forrester, T., Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia, Cardiovasc. Res., 26, 40, 1992.
231. Bodin, P., et al., Chronic hypoxia changes the ratio of endothelin to ATP release from rat aortic endothelial cells exposed to high flow, Proc. Biol. Sci., 247, 131, 1992.
232. Bodin, P. and Burnstock, G., Synergistic effect of acute hypoxia on flow-induced release of ATP from cultured endothelial cells, Experientia, 51, 256, 1995.
233. Wilson, P.D., et al., ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys, J. Am. Soc. Nephrol., 10, 218, 1999.
234. Dezaki, K., et al., Receptor-mediated facilitation of cell volume regulation by swelling-induced ATP release in human epithelial cells, Jpn. J. Physiol., 50, 235, 2000.
235. Mitchell, C.H., Release of ATP by a human retinal pigment epithelial cell line: potential for autocrine stimulation through subretinal space, J. Physiol., 534, 193, 2001.
236. Sabirov, R.Z., et al., Volume-dependent ATP-conductive large-conductance anion channel as a pathway for swelling-induced ATP release, J. Gen. Physiol., 118, 251, 2001.
237. Dutta, A.K., et al., Regulation of an ATP-conductive large-conductance anion channel and swelling-induced ATP release by arachidonic acid, J. Physiol., 542, 803, 2002.
238. Jans, D., et al., Hypotonic treatment evokes biphasic ATP release across the basolateral membrane of cultured renal epithelia (A6), J. Physiol., 545, 543, 2002.
239. Phillis, J.W. and O’Regan, M.H., Evidence for swelling-induced adenosine and adenine nucleotide release in rat cerebral cortex exposed to monocarboxylate-containing or hypotonic artificial cerebrospinal fluids, Neurochem. Int., 40, 629, 2002.
240. Goldstein, L., et al., ATP release from hypotonically stressed skate RBC: potential role in osmolyte channel regulation, J. Exp. Zoolog. A Comp. Exp. Biol., 296, 160, 2003.
241. Gheorghiu, M. and Van Driessche, W., Modeling of basolateral ATP release induced by hypotonic treatment in A6 cells, Eur. Biophys. J., 33, 412, 2004.
242. Hirakawa, M., et al., Sequential activation of RhoA and FAK/paxillin leads to ATP release and actin reorganization in human endothelium, J. Physiol., 558, 479, 2004.
243. Reigada, D. and Mitchell, C.H., Release of ATP from retinal pigment epithelial cells involves both CFTR and vesicular transport, Am. J. Physiol., 288, C132, 2005.
244. Loomis, W.H., et al., Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation, J. Biol. Chem., 278, 4590, 2003.
245. Bodas, E., et al., ATP crossing the cell plasma membrane generates an ionic current in xenopus oocytes, J. Biol. Chem., 275, 20268, 2000.
246. Dean, M., et al., The human ATP-binding cassette (ABC) transporter superfamily, Genome Res., 11, 1156, 2001.
247. Dean, M. and Annilo, T., Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates, Annu. Rev. Genomics Hum. Genet., 6, 123, 2005.
248. Uitto, J., The gene family of ABC transporters-novel mutations, new phenotypes, Trends Mol. Med., 11, 341, 2005.
249. Schwiebert, E.M., et al., CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP, Cell, 81, 1063, 1995.
250. Prat, A.G., et al., Cellular ATP release by the cystic fibrosis transmembrane conductance regulator, Am. J. Physiol., 270, C538, 1996.
251. Abraham, E.H., et al., Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate, Science, 275, 1324, 1997.
252. Jiang, Q., et al., Cystic fibrosis transmembrane conductance regulator-associated ATP release is controlled by a chloride sensor, J. Cell. Biol., 143, 645, 1998.
253. Olearczyk, J.J., et al., Receptor-mediated activation of the heterotrimeric G-protein Gs results in ATP release from erythrocytes, Med. Sci. Monit., 7, 669, 2001.
254. Sprague, R.S., et al., Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release, Am. J. Physiol., 281, C1158, 2001.
255. Ballerini, P., et al., Glial cells express multiple ATP binding cassette proteins which are involved in ATP release, Neuroreport, 13, 1789, 2002.
256. Naumann, N., et al., P-glycoprotein expression increases ATP release in respiratory cystic fibrosis cells, J. Cyst. Fibros., 4, 157, 2005.
257. Abraham, E.H., et al., The multidrug resistance (mdr1) gene product functions as an ATP channel, Proc. Natl. Acad. Sci. USA, 90, 312, 1993.
258. Reisin, I.L., et al., The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel, J. Biol. Chem., 269, 20584, 1994.
259. Cantiello, H.F., et al., Electrodiffusional ATP movement through the cystic fibrosis transmembrane conductance regulator, Am. J. Physiol., 274, C799, 1998.
260. Konig, J., et al., No evidence for inhibition of ENaC through CFTR-mediated release of ATP, Biochim. Biophys. Acta, 1565, 17, 2002.
261. Huang, P., et al., Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells, Proc. Natl. Acad. Sci. USA, 98, 14120, 2001.
262. Tarran, R., et al., Normal and cystic fibrosis airway surface liquid homeostasis. The effects of phasic shear stress and viral infections, J. Biol. Chem., 280, 35751, 2005.
263. Tarran, R., et al., Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress, Annu. Rev. Physiol., 2005.
264. Rius, M., et al., Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane, Hepatology, 38, 374, 2003.
265. Nies, A.T., et al., Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain, Neuroscience, 129, 349, 2004.
266. Bennett, M.V., et al., Structure-function studies of voltage sensitivity of connexins, the family of gap junction forming proteins, Jpn. J. Physiol., 43, S301, 1993.
267. Bennett, M.V., et al., The connexins and their family tree, Soc. Gen. Physiol. Ser., 49, 223, 1994.
268. Saez, J.C., et al., Plasma membrane channels formed by connexins: their regulation and functions, Physiol. Rev., 83, 1359, 2003.
269. Goldberg, G.S., et al., Selective transfer of endogenous metabolites through gap junctions composed of different connexins, Nat. Cell Biol., 1, 457, 1999.
270. Goldberg, G.S., et al., Gap junctions between cells expressing connexin 43 or 32 show inverse permselectivity to adenosine and ATP, J. Biol. Chem., 277, 36725, 2002.
271. Alexander, D.B. and Goldberg, G.S., Transfer of biologically important molecules between cells through gap junction channels, Curr. Med. Chem., 10, 2045, 2003.
272. Ebihara, L., New roles for connexons, News Physiol. Sci., 18, 100, 2003.
273. Saez, J.C., et al., Gap junction hemichannels in astrocytes of the CNS, Acta Physiol. Scand., 179, 9, 2003.
274. Saez, J.C., et al., Connexin-based gap junction hemichannels: gating mechanisms, Biochim. Biophys. Acta., 1711, 215, 2005.
275. Li, H., et al., Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells, J. Cell Biol., 134, 1019, 1996.
276. Quist, A.P., et al., Physiological role of gap-junctional hemichannels. Extracellular calcium-dependent isosmotic volume regulation, J. Cell Biol., 148, 1063, 2000.
277. John, S.A., et al., Connexin-43 hemichannels opened by metabolic inhibition, J. Biol. Chem., 274, 236, 1999.
278. Trexler, E.B., et al., Voltage gating and permeation in a gap junction hemichannel, Proc. Natl. Acad. Sci. USA, 93, 5836, 1996.
279. Cotrina, M.L., et al., Connexins regulate calcium signaling by controlling ATP release, Proc. Natl. Acad. Sci. USA, 95, 15735, 1998.
280. Scemes, E., Components of astrocytic intercellular calcium signaling, Mol. Neurobiol., 22, 167, 2000.
281. Braet, K., et al., Astrocyte-endothelial cell calcium signals conveyed by two signalling pathways, Eur. J. Neurosci., 13, 79, 2001.
282. Leybaert, L., et al., Connexin channels, connexin mimetic peptides and ATP release, Cell Commun. Adhes., 10, 251, 2003.
283. Leybaert, L., et al., Calcium signal communication between glial and vascular brain cells, Acta Neurol. Belg., 104, 51, 2004.
284. Schwiebert, E.M., Extracellular ATP-mediated propagation of Ca2+ waves. Focus on “mechanical strain-induced Ca2+ waves are propagated via ATP release and purinergic receptor activation,” Am. J. Physiol., 279, C281, 2000.
285. Verderio, C. and Matteoli, M., ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-β, J. Immunol., 166, 6383, 2001.
286. Stout, C.E., et al., Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels, J. Biol. Chem., 277, 10482, 2002.
287. Yao, J., et al., ATP-dependent mechanism for coordination of intercellular Ca2+ signaling and renin secretion in rat juxtaglomerular cells, Circ. Res., 93, 338, 2003.
288. Suadicani, S.O., et al., Slow intercellular Ca2+ signaling in wild-type and Cx43-null neonatal mouse cardiac myocytes, Am. J. Physiol., 279, H3076, 2000.
289. Scemes, E., et al., Intercellular communication in spinal cord astrocytes: fine tuning between gap junctions and P2 nucleotide receptors in calcium wave propagation, J. Neurosci., 20, 1435, 2000.
290. Bennett, M.V., et al., Gap junctions: new tools, new answers, new questions, Neuron, 6, 305, 1991.
291. Spray, D.C., Molecular physiology of gap junction channels, Clin. Exp. Pharmacol. Physiol., 23, 1038, 1996.
292. Boitano, S. and Evans, W.H., Connexin mimetic peptides reversibly inhibit Ca2+ signaling through gap junctions in airway cells, Am. J. Physiol., 279, L623, 2000.
293. Evans, W.H. and Boitano, S., Connexin mimetic peptides: specific inhibitors of gap-junctional intercellular communication, Biochem. Soc. Trans., 29, 606, 2001.
294. Chaytor, A.T., et al., Connexin-mimetic peptides dissociate electrotonic EDHF-type signalling via myoendothelial and smooth muscle gap junctions in the rabbit iliac artery, Br. J. Pharmacol., 144, 108, 2005.
295. Braet, K., et al., Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells, J. Cell. Physiol., 197, 205, 2003.
296. De Vuyst, E., et al., Intracellular calcium changes trigger connexin 32 hemichannel opening, EMBO J., 25, 34, 2006.
297. Bruzzone, R., et al., Pannexins, a family of gap junction proteins expressed in brain, Proc. Natl. Acad. Sci. USA, 100, 13644, 2003.
298. Bao, L., et al., Pannexin membrane channels are mechanosensitive conduits for ATP, FEBS Lett., 572, 65, 2004.
299. Baranova, A., et al., The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins, Genomics, 83, 706, 2004.
300. Locovei, S., et al., Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium, FEBS Lett., 580, 239, 2006.
301. Scemes, E., et al., Calcium waves between astrocytes from Cx43 knockout mice, Glia, 24, 65, 1998.
302. Suadicani, S.O., et al., Acute downregulation of Cx43 alters P2Y receptor expression levels in mouse spinal cord astrocytes, Glia, 42, 160, 2003.
303. Takemura, H., et al., Hypotonicity-induced ATP release is potentiated by intracellular Ca2+ and cyclic AMP in cultured human bronchial cells, Jpn. J. Physiol., 53, 319, 2003.
304. Strange, K., et al., Cellular and molecular physiology of volume-sensitive anion channels, Am. J. Physiol., 270, C711, 1996.
305. Nilius, B. and Droogmans, G., Amazing chloride channels: an overview, Acta Physiol. Scand., 177, 119, 2003.
306. Kimura, C., et al., Hypotonic stress-induced NO production in endothelium depends on endogenous ATP, Biochem. Biophys. Res. Commun., 274, 736, 2000.
307. Koyama, T., et al., Involvement of Rho-kinase and tyrosine kinase in hypotonic stress-induced ATP release in bovine aortic endothelial cells, J. Physiol., 532, 759, 2001.
308. Carton, I., et al., RhoA exerts a permissive effect on volume-regulated anion channels in vascular endothelial cells, Am. J. Physiol., 283, C115, 2002.
309. Nilius, B., et al., Role of Rho and Rho kinase in the activation of volume-regulated anion channels in bovine endothelial cells, J. Physiol., 516, 67, 1999.
310. Droogmans, G., et al., Sulphonic acid derivatives as probes of pore properties of volume-regulated anion channels in endothelial cells, Br. J. Pharmacol., 128, 35, 1999.
311. Falke, L.C. and Misler, S., Activity of ion channels during volume regulation by clonal N1E115 neuroblastoma cells, Proc. Natl. Acad. Sci. USA, 86, 3919, 1989.
312. Jalonen, T., Single-channel characteristics of the large-conductance anion channel in rat cortical astrocytes in primary culture, Glia, 9, 227, 1993.
313. Kimelberg, H.K., et al., Functional consequences of astrocytic swelling, Prog. Brain Res., 94, 57, 1992.
314. Schwiebert, E.M., et al., Adenosine regulates a chloride channel via protein kinase C and a G protein in a rabbit cortical collecting duct cell line, J. Clin. Invest., 89, 834, 1992.
315. Schwiebert, E.M., et al., Actin-based cytoskeleton regulates a chloride channel and cell volume in a renal cortical collecting duct cell line, J. Biol. Chem., 269, 7081, 1994.
316. Sabirov, R.Z. and Okada, Y., Wide nanoscopic pore of maxi-anion channel suits its function as an ATP-conductive pathway, Biophys. J., 87, 1672, 2004.
317. Shoshan-Barmatz, V. and Gincel, D., The voltage-dependent anion channel: characterization, modulation, and role in mitochondrial function in cell life and death, Cell Biochem. Biophys., 39, 279, 2003.
318. Cheng, E.H., et al., VDAC2 inhibits BAK activation and mitochondrial apoptosis, Science, 301, 513, 2003.
319. Anflous, K., et al., Altered mitochondrial sensitivity for ADP and maintenance of creatine-stimulated respiration in oxidative striated muscles from VDAC1-deficient mice, J. Biol. Chem., 276, 1954, 2001.
320. Sampson, M.J., et al., Immotile sperm and infertility in mice lacking mitochondrial voltage-dependent anion channel type 3, J. Biol. Chem., 276, 39206, 2001.
321. Dermietzel, R., et al., Cloning and in situ localization of a brain-derived porin that constitutes a large-conductance anion channel in astrocytic plasma membranes, Proc. Natl. Acad. Sci. USA, 91, 499, 1994.
322. Bathori, G., et al., Porin is present in the plasma membrane where it is concentrated in caveolae and caveolae-related domains, J. Biol. Chem., 274, 29607, 1999.
323. Bahamonde, M.I., et al., Plasma membrane voltage-dependent anion channel mediates antiestrogen-activated maxi Cl-currents in C1300 neuroblastoma cells, J. Biol. Chem., 278, 33284, 2003.
324. Bahamonde, M.I. and Valverde, M.A., Voltage-dependent anion channel localises to the plasma membrane and peripheral but not perinuclear mitochondria, Pflugers Arch., 446, 309, 2003.
325. Buettner, R., et al., Evidence for secretory pathway localization of a voltage-dependent anion channel isoform, Proc. Natl. Acad. Sci. USA, 97, 3201, 2000.
326. Sabirov, R.Z., et al., Genetic demonstration that the plasma membrane maxi-anion channel and voltage-dependent anion channels (VDACs) are unrelated proteins, J. Biol. Chem., 2005.
327. Lowenstein, C.J., et al., Regulation of Weibel-Palade body exocytosis, Trends Cardiovasc. Med., 15, 302, 2005.
328. Volknandt, W., Vesicular release mechanisms in astrocytic signalling, Neurochem. Int., 41, 301, 2002.
329. Volknandt, W., et al., Expression and allocation of proteins of the exo-endocytotic machinery in U373 glioma cells: similarities to long-term cultured astrocytes, Cell. Mol. Neurobiol., 22, 153, 2002.
330. Wilhelm, A., et al., Localization of SNARE proteins and secretory organelle proteins in astrocytes in vitro and in situ, Neurosci. Res., 48, 249, 2004.
331. Bodin, P. and Burnstock, G., Purinergic signalling: ATP release, Neurochem. Res., 26, 959, 2001.
332. Abdipranoto, A., et al., Mechanisms of secretion of ATP from cortical astrocytes triggered by uridine triphosphate, Neuroreport, 14, 2177, 2003.
333. Baratta, R., et al., Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms, J. Mol. Med., 81, 718, 2003.
334. Anderson, C.M., et al., ATP-induced ATP release from astrocytes, J. Neurochem., 88, 246, 2004.
335. Chan, W.H., Effect of resveratrol on high glucose-induced stress in human leukemia K562 cells, J. Cell. Biochem., 94, 1267, 2005.
336. Drose, S. and Altendorf, K., Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases, J. Exp. Biol., 200, 1, 1997.
337. Chardin, P. and McCormick, F., Brefeldin A: the advantage of being uncompetitive, Cell, 97, 153, 1999.
338. Rossetto, O., et al., Tetanus and botulinum neurotoxins: turning bad guys into good by research, Toxicon, 39, 27, 2001.
339. Humeau, Y., et al., How botulinum and tetanus neurotoxins block neurotransmitter release, Biochimie, 82, 427, 2000.
340. Poulain, B., et al., In vitro physiological studies on clostridial neurotoxins. Biological models and procedures for extracellular and intracellular application of toxins, Meth. Mol. Biol., 145, 259, 2000.
341. Betz, W.J., et al., Imaging exocytosis and endocytosis, Curr. Opin. Neurobiol., 6, 365, 1996.
342. Cochilla, A.J., et al., Monitoring secretory membrane with FM1-43 fluorescence, Annu. Rev. Neurosci., 22, 1, 1999.
343. Knight, G.E., et al., ATP is released from guinea pig ureter epithelium on distension, Am. J. Physiol., 282, F281, 2002.
344. Khera, M., et al., Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury, Neurochem. Int., 45, 987, 2004.
345. Sun, Y. and Chai, T.C., Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis, Am. J. Physiol., 290, C27, 2006.
346. Bezzi, P., et al., Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate, Nat. Neurosci., 7, 613, 2004.
347. Kreft, M., et al., Properties of Ca2+-dependent exocytosis in cultured astrocytes, Glia, 46, 437, 2004.
348. Zhang, Q., et al., Fusion-related release of glutamate from astrocytes, J. Biol. Chem., 279, 12724, 2004.
349. Zhang, Q., et al., Synaptotagmin IV regulates glial glutamate release, Proc. Natl. Acad. Sci. USA, 101, 9441, 2004.
350. Crippa, D., et al., Synaptobrevin2-expressing vesicles in astrocytes: insights into molecular characterization, dynamics and exocytosis, J. Physiol., 2005.
351. Coco, S., et al., Storage and release of ATP from astrocytes in culture, J. Biol. Chem., 278, 1354, 2003.
352. Pascual, O., et al., Astrocytic purinergic signaling coordinates synaptic networks, Science, 310, 113, 2005.
353. Kittel, A. and Bacsy, E., Presynaptic ecto-and postsynaptic endo-calcium-adenosine-triphosphatases in synaptosomes: doubts about biochemical interpretation of localization, Int. J. Dev. Neurosci., 12, 207, 1994.
354. Strohmeier, G.R., et al., Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia, J. Clin. Invest., 99, 2588, 1997.
355. Vacca, F., et al., P2X3 receptor localizes into lipid rafts in neuronal cells, J. Neurosci. Res., 76, 653, 2004.
356. Quinton, T.M., et al., Lipid rafts are required in Gai signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation, J. Thromb. Haemost., 3, 1036, 2005.
357. Vial, C. and Evans, R.J., Disruption of lipid rafts inhibits P2X1 receptor-mediated currents and arterial vasoconstriction, J. Biol. Chem., 280, 30705, 2005.
358. Bal-Price, A., et al., Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes, Glia, 40, 312, 2002.
359. Brain, K.L., et al., Intermittent ATP release from nerve terminals elicits focal smooth muscle Ca2+ transients in mouse vas deferens, J. Physiol., 541, 849, 2002.
360. Katsuragi, T., et al., Inositol(1,4,5)trisphosphate signal triggers a receptor-mediated ATP release, Biochem. Biophys. Res. Commun., 293, 686, 2002.
361. Liu, G.J., et al., Secretion of ATP from Schwann cells in response to uridine triphosphate, Eur. J. Neurosci., 21, 151, 2005.
362. Migita, K., et al., Adenosine induces ATP release via an inositol 1,4,5-trisphosphate signaling pathway in MDCK cells, Biochem. Biophys. Res. Commun., 328, 1211, 2005.
363. Feranchak, A.P., et al., Phosphatidylinositol 3-kinase contributes to cell volume regulation through effects on ATP release, J. Biol. Chem., 273, 14906, 1998.
364. Feranchak, A.P., et al., The lipid products of phosphoinositide 3-kinase contribute to regulation of cholangiocyte ATP and chloride transport, J. Biol. Chem., 274, 30979, 1999.
365. Grygorczyk, R. and Guyot, A., Osmotic swelling-induced ATP release: a new role for tyrosine and Rho-kinases? J. Physiol., 532, 582, 2001.
366. Just, I. and Gerhard, R., Large clostridial cytotoxins, Rev. Physiol. Biochem. Pharmacol., 152, 23, 2004.
367. Aktories, K. and Just, I., Clostridial Rho-inhibiting protein toxins, Curr. Top. Microbiol. Immunol., 291, 113, 2005.
368. Jørgensen, N.R., et al., ATP-and gap junction-dependent intercellular calcium signaling in osteoblastic cells, J. Cell Biol., 139, 497, 1997.
369. Bowler, W.B., et al., Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling, Bone, 28, 507, 2001.
370. Romanello, M., et al., Mechanosensitivity and intercellular communication in HOBIT osteoblastic cells: a possible role for gap junction hemichannels, Biorheology, 40, 119, 2003.
371. Hayton, M.J., et al., Involvement of adenosine 5'-triphosphate in ultrasound-induced fracture repair, Ultrasound Med. Biol., 31, 1131, 2005.
372. Jørgensen, N.R., Short-range intercellular calcium signaling in bone, APMIS Suppl., 5, 2005.
373. Li, J., et al., The P2X7 nucleotide receptor mediates skeletal mechanotransduction, J. Biol. Chem., 280, 42952, 2005.
374. Buckley, K.A., et al., Release and interconversion of P2 receptor agonists by human osteoblast-like cells, FASEB J., 17, 1401, 2003.